Skyward Specialty Insurance Group, Inc. (SKWD) Stock Price & How to Invest

Skyward writes commercial property and casualty insurance in niches most carriers do not staff for. The US business is organised into nine underwriting divisions, each with dedicated leadership: Accident & Health, Captives, Credit & Surety, Energy Solutions, Global Agriculture, Global Property, Professional Lines, Specialty Programs and Transactional E&S. Second-quarter 2026 gross written premiums from those divisions came to ~$667.9M, up 14.1% year over year, with Global Agriculture nearly doubling to ~$111.9M and Accident & Health up 57.8% to ~$95.5M, while Captives, Energy Solutions and Global Property each contracted by mid-teens percentages. Management calls the approach "Rule Our Niche", and the intended consequence is that close to half the book sits in lines that do not track the property catastrophe cycle. On January 1, 2026 the company closed a ~$559.1M purchase of Apollo Group Holdings, paid for with ~$371.1M of cash and 3,679,332 Skyward shares valued at $51.11 each. Apollo underwrites through Syndicates 1969 and 1971 with its own capital and provides managing agency services to nine Lloyd's syndicates in total, which hands Skyward a fee stream on premium it does not carry: ~$318.1M of fee-generating gross written premium in the quarter.

Underwriting margin, not premium volume, is what moves the earnings. Skyward posted an 89.5% combined ratio in the second quarter of 2026 and 89.3% for full-year 2025, keeping roughly ten cents of underwriting profit on every premium dollar before any investment return. Net investment income of ~$30.7M in the quarter, up ~$12.0M year over year on a ~$2.74B portfolio, is the second leg. Together they produced ~$59.2M of operating income in the quarter, ~$1.30 per diluted share, a 46% increase, and a 19.0% annualized operating return on equity. The market is paying ~$56.89 per share for that, about 2.0x the $28.55 book value and roughly 2.9x tangible book. Trailing GAAP earnings of ~$4.30 per diluted share put the stock near 13x, and the company's own 2026 guidance of $4.50 to $4.70 of net income per diluted share brings that closer to 12x. Two line items now sit between operating and reported earnings: ~$8.8M of quarterly intangible amortization against ~$0.4M a year earlier, and interest expense of ~$8.8M against ~$1.9M, on the ~$437M of debt outstanding after funding Apollo. Underwriting income of ~$54.8M in the quarter, against ~$31.2M a year earlier, shows where the operating gain came from.

The largest exposure is reserve adequacy. Net loss reserves of ~$1,908.1M exceed shareholders' equity of ~$1,267.5M by half again, so a 5% deficiency across the book would consume roughly 7% of book value before tax. Growth compounds that: Global Agriculture premium nearly doubled year over year and Accident & Health rose 57.8%, and immature accident years in fast-growing lines are where estimation error tends to appear two or three years later. A second, less discussed exposure is credit. Reinsurance recoverables of ~$1,411.6M are larger than the entire equity base, and Skyward remains liable to policyholders if a reinsurer fails to pay. The company has also been retaining more risk itself, with net retention on a written basis rising to 65.6% in the second quarter of 2026 from 58.0% a year earlier, which raises the loss volatility that reaches the income statement. Apollo brings its own set. Goodwill and intangibles of ~$471.2M now equal ~37% of equity, including $200M of indefinite-lived syndicate capacity that is tested for impairment rather than amortised, and the 10-Q states that the assessment of internal control over financial reporting excludes Apollo while integration continues. The Lloyd's segment ran a 97.6% combined ratio in the quarter with 5.4 points of catastrophe loss attributed primarily to the conflict in the Middle East, a reminder that the acquired book carries political and war exposure the US divisions largely do not. Pricing is the background condition: management's own 2026 guidance assumes a 90.5% to 91.5% combined ratio, above the 89.5% delivered in the first half, which implies an expected second-half deterioration. Alternative and strategic investments have been a persistent drag, costing ~$8.1M in the first half of 2026 after ~$11.5M in 2025. Chief Financial Officer Mark Haushill is retiring effective March 31, 2027.

11 analysts publish price targets on SKWD, averaging $70.55 against a $56.89 price as of August 2026, or +24.0%. The published targets run from $56.00 to $80.00, a moderate spread, and the ratings split 9 buy, 4 hold, 0 sell. Over the last six months there have been 10 raises and 2 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full SKWD forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Skyward Specialty Insurance Group, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Apollo turns an underwriter into a fee earner as well. Apollo Syndicate Management runs nine Lloyd's syndicates, only some of which Skyward capitalises. The most optimistic published target, $80.00, assumes this works close to its best case.

The case against. The largest exposure is reserve adequacy. The most pessimistic target, $56.00, is roughly what SKWD is worth if this bites instead.

Read the full bull and bear case on SKWD, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Skyward Specialty Insurance Group, Inc.'s investor relations page or your broker.

• Revenue (TTM): ~$1.73B for the twelve months to June 30, 2026, against ~$1.42B in fiscal 2025, ~$1.15B in 2024 and ~$886M in 2023. The 2026 half-year figure of ~$965.4M includes Apollo for the first time, alongside ~$878.5M of net earned premium, ~$57.8M of net investment income, ~$22.7M of underwriting fee income and ~$3.9M of commission and fee income.
• Earnings and operating earnings: Second-quarter 2026 net income of ~$49.0M, or ~$1.07 per diluted share, and operating income of ~$59.2M, or ~$1.30 per diluted share, up 46% year over year. First-half net income was ~$98.8M (~$2.17 diluted) and operating income ~$116.1M (~$2.55 diluted). Full-year 2025 delivered ~$170.0M of net income (~$4.07 diluted) and ~$167.4M of adjusted operating income (~$4.00). Trailing twelve-month diluted EPS is ~$4.30.
• Underwriting metrics: Combined ratio of 89.5% in the second quarter of 2026 (62.3% loss, 27.2% expense), 87.6% excluding 1.9 points of catastrophe loss, versus 89.3% for full-year 2025 and 92.3% for 2024. By segment, Skyward Specialty ran 86.9% and Apollo 97.6%. Gross written premiums were ~$740.6M in the quarter and ~$2,166.2M for full-year 2025; ceded written premium of ~$254.9M in the quarter left ~$485.6M net written and ~$444.5M net earned, a 65.6% net retention.
• Book value and returns: Book value per share of $28.55 at June 30, 2026, up 14.6% from $24.92 at December 31, 2025, which had itself risen 26% during 2025. Fully diluted book value per share was $27.20 and tangible shareholders' equity ~$861.9M, or roughly $19.41 per share. Annualized return on equity was 15.7% for the quarter and 17.3% for the half; annualized operating ROE was 19.0% and 20.4%, and operating return on tangible equity 28.2% and 26.0%.
• Balance sheet: Total assets of ~$6.78B at June 30, 2026 against ~$4.79B at year-end 2025, reflecting the Apollo consolidation. Investments totalled ~$2.74B with ~$219.2M of cash, ~$83.3M restricted cash and ~$121.6M of Funds at Lloyd's. Reserves for losses and loss adjustment expenses were ~$3.07B gross and ~$1.91B net; reinsurance recoverables ~$1.41B. Debt stood at ~$417.6M of notes payable plus ~$19.6M of subordinated notes after a $50.0M term loan repayment in June, against ~$1,267.5M of equity.
• Market pricing: Shares trade near ~$56.89 for a market value of ~$2.5B on ~44.4M shares outstanding, within a 52-week range of ~$40.60 to ~$65.69. The stock therefore changes hands at ~13x trailing diluted earnings, ~2.0x book value and ~2.9x tangible book, and roughly 12x the $4.50 to $4.70 of 2026 net income per diluted share the company guided to in December 2025. No dividend is paid. Reported beta is ~0.33. Published analyst price targets average ~$70.55.

A screener's 1.3x price-to-sales figure carries almost no signal for SKWD, because insurance revenue is premium the company has already promised to pay claims against. The multiple that carries information is price to book, and at ~2.0x the stock sits well below the ~4x to 5x that the market has awarded the fastest-growing US excess and surplus underwriters, and above the ~1.3x to 1.5x typical of carriers whose returns hover near their cost of capital. On tangible book the gap narrows, since ~$471.2M of the equity base is now goodwill and intangibles from Apollo.

Other names that sit close to SKWD: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get SKWD exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so SKWD sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where SKWD fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

As of August 2026, SKWD is priced near 2.0x book value and about 12x the midpoint of management's own 2026 net income guidance, roughly where the market has been valuing specialty underwriters that earn a high-teens operating return on equity without leaning on prior-year reserve releases. The unsettled part is Apollo: goodwill and intangibles now equal ~37% of shareholders' equity, and the Lloyd's segment ran a 97.6% combined ratio in its second quarter under Skyward ownership.

Whether SKWD is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is SKWD a buy or a sell?, and where the stock could go from here in the SKWD stock forecast.

For income investors, whether SKWD pays a dividend and how the payout looks is covered in does SKWD pay a dividend? And to weigh SKWD against a peer, read the full side-by-side comparisons: SKWD vs KNSL and SKWD vs WRB.